Mice with HCC70-Mut PIK3CA tumors and treated with TCR4 had a significant reduction in tumor volumes and enhanced survival compared to mice that received the Flu-specific TCR or PBS controls (Fig. 5b,c and Supplementary Fig. 10a). This evidence concerns the gene PIK3CA and neoplasm.